IGC Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1.11	0.41	1.2	3.2	10.46	14.55
Short-Term Investments	0.03	-	-	0.15	-	0.08
Cash & Short-Term Investments	1.13	0.41	1.2	3.35	10.46	14.63
Cash Growth	-26.91%	-66.19%	-64.24%	-67.97%	-28.49%	18.55%
Accounts Receivable	0.04	0	0.04	0.11	0.13	0.18
Inventory	0.76	1.36	1.54	2.65	3.55	5.48
Other Current Assets	0.18	1.13	0.93	0.36	0.98	3.24
Total Current Assets	2	2.9	3.71	6.47	15.11	23.52
Net Property, Plant & Equipment	0.01	0.1	0.2	0.33	0.45	0.49
Other Intangible Assets	4.88	1.85	1.62	1.17	0.92	0.41
Long-Term Investments	-	-	-	-	-	0.01
Other Long-Term Assets	0.67	0.68	0.69	1	0.94	0.6
Total Assets	9.74	8.75	9.9	17.18	26.83	35.87
Accounts Payable	0.63	0.88	0.77	0.53	0.98	0.48
Accrued Expenses	0.89	1.37	1.57	1.37	1.46	1.59
Short-Term Debt	-	-	-	-	-	0.3
Total Current Liabilities	1.51	2.26	2.34	1.9	2.44	2.37
Long-Term Debt	0.13	0.13	0.14	0.14	0.14	0.28
Long-Term Leases	0.01	0.01	0.08	0.21	0.34	0.41
Other Long-Term Liabilities	-	0.02	0.02	0.02	0.02	0.02
Total Long-Term Liabilities	0.14	0.16	0.24	0.37	0.5	0.7
Total Liabilities	1.65	2.42	2.58	2.27	2.94	3.06
Common Stock	135.77	130.58	124.41	118.97	116.02	109.72
Accumulated Other Comprehensive Income	-2.85	-3.5	-3.42	-3.39	-2.97	-2.77
Retained Earnings	-122.83	-120.74	-113.67	-100.67	-89.16	-74.14
Total Common Shareholders' Equity	10.09	6.34	7.32	14.91	23.89	32.8
Shareholders' Equity	8.09	6.33	7.32	14.91	23.89	32.8
Total Liabilities & Equity	9.74	8.75	9.9	17.18	26.83	35.87
Total Debt	0.14	0.14	0.22	0.35	0.49	0.99
Net Cash (Debt)	0.99	0.26	0.98	3	9.98	13.64
Net Cash Growth	280.46%	-73.29%	-67.45%	-69.91%	-26.89%	15.58%
Net Cash Per Share	0.01	0.00	0.02	0.06	0.20	0.33
Book Value	10.09	6.34	7.32	14.91	23.89	32.8
Book Value Per Share	0.12	0.08	0.12	0.28	0.48	0.78
Tangible Book Value	5.21	4.49	5.71	13.74	22.98	32.4
Tangible Book Value Per Share	0.06	0.06	0.10	0.26	0.46	0.77

SEC Filings: 10-K · 10-Q